import type { SuggestedQuestion } from './types';

export const SUGGESTED_QUESTIONS: SuggestedQuestion[] = [
  {
    id: '5',
    question: '¿Qué productos o coberturas son más susceptibles de fraude o mal uso, según patrones históricos?',
    reasoning: 'We aggregated claims flagged by the fraud detection engine over the past five years and clustered them by product line. The cluster with the highest frequency of anomalies was tied to minor medical expenses with extended dental coverage. Further spatial analysis using postal codes revealed a pattern: multiple insureds from the same area filing similar claims. We also checked provider IDs and found that many claims originated from out-of-network clinics with irregular billing histories. Temporal analysis showed these claims often occurred outside normal business hours. Pulling these variables together painted a clear risk profile around this specific product and scenario.',
    answer: `El producto con más alertas por posible uso indebido es el **Seguro de gastos menores con cobertura dental ampliada**.

- **78% de los casos sospechosos** tienen patrones similares: múltiples asegurados del mismo código postal, clínicas fuera de red con historial irregular, montos similares y horarios nocturnos.`
  },
  {
    id: '4',
    question: '¿Qué microsegmentos dentro de mi cartera tienen alta frecuencia pero baja severidad, y podrían ser redireccionados a programas de prevención?',
    reasoning: 'Analyzing historical claim data, we first filtered by visit frequency over the past 24 months to identify insured members with more than 6 consultations per year. We then intersected this cohort with cost data to isolate those with a relatively low average ticket size. Further segmentation by diagnosis codes highlighted a concentration of individuals with chronic anxiety. We noticed most had no formal treatment plan recorded. By cross-referencing age distributions and verifying hospital admission histories, we found a group with zero hospitalizations in two years. This suggests persistent low-acuity utilization. Combining these attributes, we identified a candidate segment that could be steered toward low-cost digital interventions to potentially reduce unnecessary consultations.',
    answer: `Encontramos un microgrupo de 11,500 asegurados:
- **Edad 29-42**, con ansiedad crónica, sin tratamiento formal.
- Consultan medicina general **6+ veces al año**.
- **Sin hospitalizaciones** en 24 meses.

Este grupo genera alta frecuencia (11.3 visitas/año promedio), pero con ticket promedio de $1,520. Se sugiere canalización a programas digitales de atención emocional.`
  },
  {
    id: '1',
    question:
      'Una mujer de 30 años presenta antecedentes de picazón debajo de la mama derecha y presenta una lesión anular en el examen. ¿Cuál es el hongo más probable que causa esta afección?',
    reasoning:
      "Okay, so I need to figure out the most likely fungal organism causing an annular ring lesion under a 30-year-old female's right breast. Let me start by recalling what an annular lesion usually indicates. An annular ring-shaped lesion is typical of certain skin infections. Since the question mentions a fungal organism, it's probably a type of dermatophyte infection. Dermatophytes are fungi that cause infections like tinea corporis (ringworm), tinea cruris (jock itch), and tinea pedis (athlete's foot). The location here is under the breast, which is a warm, moist area. That makes me think of tinea versicolor or maybe candidiasis, but tinea versicolor usually presents with discolored patches, not so much itching. Candidiasis can cause itching and redness in skin folds, but the annular lesion makes me lean more towards a dermatophyte. Wait, tinea corporis presents as an annular, scaly plaque with central clearing and an active red border. That fits the description here. The most common dermatophytes are Trichophyton, Microsporum, and Epidermophyton. Among these, Trichophyton species like T. rubrum are the most common cause of tinea corporis. But wait, the location is under the breast, which is a intertriginous area. Could it be tinea cruris instead? But tinea cruris usually affects the groin. However, dermatophytes can infect any body part, so maybe it's tinea corporis in an intertriginous area. Alternatively, Candida can cause infections in skin folds, presenting as red, macerated patches with satellite lesions. But Candida is a yeast, not a dermatophyte. The question specifies a fungal organism, which Candida is, but the annular ring makes me think more dermatophyte. However, sometimes Candida can have satellite lesions which might not be annular. Let me check some details. Tinea corporis typically has an annular appearance with central clearing and a scaly advancing border. The itching supports this. The location under the breast, being a warm and sweaty area, is a risk factor for fungal infections. So dermatophytes thrive there. The most common species causing tinea corporis is Trichophyton rubrum, followed by T. mentagrophytes and others. So the answer is likely Trichophyton rubrum. But I should also consider other possibilities. Could it be Microsporum? That's more common in tinea capitis. Epidermophyton causes tinea cruris and tinea pedis. Alternatively, is there a different fungal infection that presents with annular lesions? Pityriasis rosea is another annular rash, but that's viral and not fungal. So going back, the most probable is a dermatophyte, specifically Trichophyton species. Therefore, the most likely fungal organism is Trichophyton rubrum.",
    answer: `El hongo más probable que causa la lesión anular debajo de la mama es **Trichophyton rubrum**.

**Puntos clave:**
- **La lesión anular con picazón** es clásica de la **tinea corporis** (tiña), una infección por dermatofitos.
- **La ubicación** (pliegue cutáneo cálido y húmedo) favorece el crecimiento de hongos, y dermatofitos como las especies de *Trichophyton* prosperan en estos entornos.
- **Trichophyton rubrum** es el dermatofito más común responsable de la tiña corporis, que se caracteriza por placas eritematosas y escamosas con un centro claro y un borde activo.
- Otras posibilidades, como *Candida* (levadura), son menos probables debido a la morfología anular, más típica de los dermatofitos.

**Diagnóstico:** Tiña corporal causada por *Trichophyton rubrum*. **Próximos pasos:** Confirmar con microscopía de hidróxido de potasio (KOH) y tratar con antimicóticos tópicos (p. ej., clotrimazol, terbinafina).`,
  },
  {
    id: '2',
    question:
      'Un hombre de 38 años presenta diarrea, cólicos abdominales y heces de color rojo oscuro tras un viaje maratónico a México. Un coprocultivo muestra microorganismos en los eritrocitos ingeridos. Considerando este cuadro clínico y los hallazgos de laboratorio, ¿cuál es el tratamiento farmacológico más adecuado para iniciar junto con la terapia de soporte?',
    reasoning:
      "Okay, let's tackle this question. So, we have a 38-year-old man who went to Mexico for a marathon trip and now has diarrhea, abdominal cramps, and dark red-tinted stools. The stool culture shows organisms with ingested erythrocytes. The question is asking for the most appropriate pharmacological treatment alongside supportive therapy. First, let me think about the symptoms. Diarrhea and abdominal cramps are common with gastrointestinal infections. The dark red-tinted stools suggest there's blood in the stool, which points towards something causing bleeding in the intestines. So, possible causes could be bacterial infections like Shigella, Salmonella, Campylobacter, E. coli, or maybe parasites like Entamoeba histolytica. The key clue here is the stool culture showing organisms with ingested erythrocytes. That makes me think of Entamoeba histolytica because amoebic dysentery is known for causing bloody diarrhea and the trophozoites of E. histolytica can ingest red blood cells, which would be visible on a stool sample. Bacterial causes like Shigella might also cause bloody diarrhea, but the ingested erythrocytes in the organisms seen in the culture are more characteristic of amoebiasis. So, if it's amoebic dysentery, the treatment would involve medications that target the parasite. Metronidazole is usually the first-line treatment for invasive amoebiasis. It's effective against the trophozoites in the intestinal wall and other tissues. However, since metronidazole doesn't eradicate the cysts in the intestinal lumen, a luminal agent like paromomycin or iodoquinol is often added to prevent relapse. But the question is asking for the most appropriate pharmacological treatment to initiate alongside supportive therapy. Supportive therapy would include rehydration, possibly with oral rehydration solutions or IV fluids if needed, and managing symptoms. So, the main drug here would be metronidazole. Maybe they want just the primary treatment, not the combination. However, sometimes both are started together. But in some settings, especially in areas where amoebiasis is common, like Mexico, metronidazole alone might be initiated first followed by a luminal agent. But the question mentions initiating alongside supportive therapy, so maybe they expect metronidazole as the answer. Alternatively, if it's a bacterial cause like Shigella, the treatment would be antibiotics like ciprofloxacin or azithromycin. But the ingested erythrocytes in the stool culture pointing to the organism having phagocytosed red blood cells is more indicative of Entamoeba. Shigella doesn't typically ingest RBCs; they invade the mucosa but the bacteria themselves don't show ingested RBCs under the microscope. Another possibility is Balantidium coli, which can also cause dysentery and ingest RBCs, but it's less common. However, the most common protozoan causing dysentery with that feature is Entamoeba histolytica. So, putting this together, the treatment for amoebiasis is metronidazole. Therefore, the answer should be metronidazole. But let me check if there are any other considerations. For example, if the patient has a severe case or complications, but the question doesn't mention that. Supportive therapy is already part of the management, so the pharmacological part is metronidazole. Additionally, maybe tinidazole is an alternative, but metronidazole is more commonly used first-line.",
    answer: `Los síntomas del paciente: diarrea sanguinolenta (heces de color rojo oscuro), cólicos abdominales y un viaje reciente a México, junto con los hallazgos en el coprocultivo de microorganismos con eritrocitos ingeridos, sugieren fuertemente **disentería amebiana causada por *Entamoeba histolytica***. Este parásito protozoario invade la mucosa intestinal, causando daño tisular y trofozoítos hematófagos visibles al microscopio.

**Tratamiento farmacológico más adecuado**:
**El metronidazol** (un nitroimidazol) es el tratamiento de primera línea para la amebiasis intestinal invasiva. Actúa eficazmente sobre los trofozoítos en la pared intestinal y otros tejidos.

**Consideración adicional**:
Tras completar el tratamiento con metronidazol, se suele recetar un **agente luminal** (p. ej., paromomicina o yodoquinol) para eliminar los quistes residuales en el lumen intestinal y prevenir recaídas. Sin embargo, la pregunta especifica que el tratamiento debe iniciarse *junto con la terapia de soporte*, por lo que el metronidazol solo es la respuesta inmediata.

**¿Por qué no antibióticos para causas bacterianas?**
Si bien patógenos bacterianos como *Shigella* o *Campylobacter* pueden causar diarrea sanguinolenta, el hallazgo clave de **organismos que ingieren eritrocitos** es patognomónico de *E. histolytica*. Los cultivos bacterianos no mostrarían esta característica.

**Respuesta**: El **metronidazol** debe iniciarse junto con la terapia de soporte (p. ej., rehidratación).`,
  },
  {
    id: '3',
    question: 'Una mujer de 42 años presenta síntomas de depresión, como llanto frecuente, sentimientos de tristeza y culpa, dificultad para dormir, despertares tempranos y pérdida de peso significativa en las últimas tres semanas. Tiene antecedentes de anorexia nerviosa y desea recuperar peso. Durante su examen del estado mental, presenta un estado de ánimo deprimido y apatía aplanada sin ideación suicida. Considerando sus antecedentes y deseos, ¿qué medicamento es el más adecuado para abordar simultáneamente sus síntomas depresivos y ayudarla a subir de peso?',
    reasoning: "Okay, so I need to figure out which medication would be best for this 42-year-old woman with depression symptoms and a history of anorexia nervosa, who wants to gain weight. Let me start by recalling what I know about antidepressants and their effects on weight. First, her main symptoms are depression with crying, sadness, guilt, insomnia, early morning awakening, and significant weight loss. She also has a history of anorexia and wants to regain weight. The mental status exam shows depressed mood, flat affect, but no suicidal thoughts. So, the key here is choosing an antidepressant that not only treats her depressive symptoms but also helps with weight gain. I remember that different antidepressants have different side effect profiles. For example, SSRIs like fluoxetine (Prozac) are commonly used for depression, but some can cause weight loss or suppress appetite, which isn't good here. However, I think some antidepressants might actually cause weight gain as a side effect, which could be beneficial in her case. Let me list some antidepressants and their weight effects. SSRIs: Fluoxetine can sometimes cause initial weight loss but maybe long-term weight gain. Sertraline (Zoloft) and paroxetine (Paxil) – I think paroxetine is more associated with weight gain. Then there's mirtazapine (Remeron), which is known for causing significant weight gain and increased appetite. That's often used in patients who need to gain weight. Another one is tricyclic antidepressants like amitriptyline, which can also cause weight gain, but they have more side effects and maybe not the first choice now. Bupropion (Wellbutrin) is an atypical antidepressant that's usually weight-neutral or can cause weight loss, so that's probably not good here. Also, considering her insomnia and early morning awakenings, which are symptoms that might be part of a melancholic or atypical depression. Mirtazapine has sedative properties, which could help with sleep, especially at lower doses. On the other hand, SSRIs like fluoxetine can be activating and might worsen insomnia, though sometimes they're given in the morning to mitigate that. So, given her need for weight gain and depressive symptoms, mirtazapine seems like a strong candidate. It's known to increase appetite and promote weight gain, which would align with her history of anorexia and current desire to regain weight. It also helps with sleep due to its sedating effects, which could address her insomnia and early morning awakenings. Additionally, mirtazapine is effective for depression with symptoms like weight loss and sleep disturbances. Another option could be a TCA like amitriptyline, but the side effect profile is worse (anticholinergic effects, cardiac issues), especially in someone with a possible history of eating disorders where electrolyte imbalances might be a concern. SSRIs like paroxetine might have some weight gain, but maybe not as much as mirtazapine. Also, paroxetine has more anticholinergic effects and is generally not preferred for long-term use due to withdrawal issues. So, putting it all together: Mirtazapine is likely the best choice here because it addresses both depressive symptoms and promotes weight gain. It also helps with sleep, which is another of her symptoms. The fact that she wants to regain weight makes the side effect of increased appetite a therapeutic advantage in this case.",
    answer: "El medicamento más adecuado para esta paciente es la **mirtazapina**. La justificación es la siguiente:\n\n1. **Aumento de Peso y Estimulación del Apetito**: La mirtazapina es conocida por su efecto secundario de aumentar el apetito y promover el aumento de peso, lo cual se alinea directamente con el objetivo de la paciente de recuperar su peso, especialmente dado su historial de anorexia nerviosa.\n\n2. **Síntomas Depresivos**: Es eficaz en el tratamiento del trastorno depresivo mayor, abordando sus síntomas de bajo estado de ánimo, culpa y tristeza. Su mecanismo de acción (actividad noradrenérgica y serotoninérgica específica) es diferente al de los ISRS/IRSN, lo que la convierte en una buena alternativa.\n\n3. **Mejora del Sueño**: La mirtazapina tiene fuertes efectos sedantes, especialmente en dosis bajas, lo que ayudaría a aliviar el insomnio y los despertares matutinos, comunes en la depresión melancólica.\n\n4. **Perfil de seguridad**: A diferencia de los ATC (p. ej., amitriptilina), la mirtazapina carece de efectos secundarios anticolinérgicos o cardíacos significativos, lo que reduce el riesgo en pacientes potencialmente vulnerables a desequilibrios electrolíticos. Además, carece de los efectos activadores de los ISRS (p. ej., fluoxetina), que podrían agravar el insomnio.\n\n**Alternativas consideradas y rechazadas**:\n- **ISRS (p. ej., paroxetina)**: Si bien algunos ISRS pueden causar aumento de peso, son menos fiables para este fin y pueden agravar el insomnio.\n- **Bupropión**: Contraindicado debido a su asociación con pérdida de peso y supresión del apetito.\n- **ATC**: Mayor riesgo de efectos adversos (p. ej., arritmias, efectos anticolinérgicos) en comparación con la mirtazapina.\n\n**Conclusión**: La mirtazapina equilibra de forma óptima la eficacia para la depresión, los beneficios del aumento de peso y la mejora del sueño, lo que la convierte en la mejor opción para este paciente."
  },
];
